{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T05:07:26Z","timestamp":1736831246531,"version":"3.33.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.rceng.2024.10.008","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T07:40:45Z","timestamp":1730274045000},"page":"51-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-NOR90 antibodies and their clinical significance: a multicenter experience in southern Spain"],"prefix":"10.1016","volume":"225","author":[{"given":"J.","family":"Mart\u00ednez de Victoria Carazo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Fern\u00e1ndez Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.J.","family":"de la Hera Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Gonz\u00e1lez Cejudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Navarrete Navarrete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Callejas Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.rceng.2024.10.008_bib0005","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.4049\/jimmunol.139.8.2579","article-title":"Anti-NOR 90. A new autoantibody in scleroderma that recognizes a 90-kDa component of the nucleolus-organizing region of chromatin","volume":"139","author":"Rodriguez-Sanchez","year":"1987","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.rceng.2024.10.008_bib0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00997157","article-title":"Immunocytochemical characterization of human NOR-90 (upstream binding factor) and associated antigens reactive with autoimmune sera. Two MR forms of NOR-90\/hUBF autoantigens","volume":"19","author":"Imai","year":"1994","journal-title":"Mol Biol Rep."},{"issue":"1","key":"10.1016\/j.rceng.2024.10.008_bib0015","first-page":"67","article-title":"Clinical relevance and HLA association of autoantibodies against the nucleolus organizer region (NOR-90)","volume":"22","author":"Dick","year":"1995","journal-title":"J Rheumatol."},{"issue":"3","key":"10.1016\/j.rceng.2024.10.008_bib0020","first-page":"521","article-title":"Autoantibodies to the nucleolar organizer antigen NOR-90 in children with systemic rheumatic diseases","volume":"22","author":"Fritzler","year":"1995","journal-title":"J Rheumatol."},{"issue":"8","key":"10.1016\/j.rceng.2024.10.008_bib0025","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/art.1780390808","article-title":"Detection of autoantibodies to nucleolar transcription factor NOR 90\/hUBF in sera of patients with rheumatic diseases, by recombinant autoantigen-based assays","volume":"39","author":"Fujii","year":"1996","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.rceng.2024.10.008_bib0030","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/rheumatology\/keab575","article-title":"Clinical significance of anti-NOR90 antibodies in systemic sclerosis and idiopathic interstitial pneumonia","volume":"61","author":"Yamashita","year":"2022","journal-title":"Rheumatology (Oxford)."},{"issue":"7","key":"10.1016\/j.rceng.2024.10.008_bib0035","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/08916934.2017.1357699","article-title":"Disease-related autoantibody profile in patients with systemic sclerosis","volume":"50","author":"Liaskos","year":"2017","journal-title":"Autoimmunity."},{"issue":"7","key":"10.1016\/j.rceng.2024.10.008_bib0040","first-page":"1543","article-title":"Autoantibodies to NOR 90\/hUBF: longterm clinical and serological followup in a patient with limited systemic sclerosis suggests an antigen driven immune response","volume":"29","author":"Dagher","year":"2002","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.rceng.2024.10.008_bib0045","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s10067-022-06487-3","article-title":"Diagnostic accuracy and predictive value of autoantibody profiles in patients with systemic sclerosis: a single-center study","volume":"42","author":"Zhang","year":"2023","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.rceng.2024.10.008_bib0050","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejim.2024.03.035","article-title":"Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review","volume":"125","author":"Dima","year":"2024","journal-title":"Eur J Intern Med"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2254887424001383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2254887424001383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T08:28:51Z","timestamp":1736756931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2254887424001383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2254887424001383"],"URL":"https:\/\/doi.org\/10.1016\/j.rceng.2024.10.008","relation":{},"ISSN":["2254-8874"],"issn-type":[{"type":"print","value":"2254-8874"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-NOR90 antibodies and their clinical significance: a multicenter experience in southern Spain","name":"articletitle","label":"Article Title"},{"value":"Revista Cl\u00ednica Espa\u00f1ola (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rceng.2024.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rce.2024.08.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Medicina Interna (SEMI). All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}